Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to presentation of Prevas’ interim report January – June 2024

Prevas will publish the interim report for January-June 2024 on Friday, July 19, at 08:30. On the same day at 09.30 a.m. a press and analyst presentation will be held which can be followed via webcast with Finwire.[En bild som visar text, skärmbild, visitkort, Teckensnitt Automatiskt genererad beskrivning] The presentation is given in English by Magnus Welén (CEO) and Helena Burström (CFO) from Prevas AB. The presentation will be about Prevas’ development during the second quarter and first half of 2024. Follow the presentation here: https://www.finwire.tv/webcast/prevas/q2-2024/

Draft Determination

LEI 2138006E2VG89XLORJ06 Yorkshire Water receives PR24 draft determination from Ofwat   We submitted a substantial business plan to Ofwat outlining details of the investment we would like to make from 2025-2030.  Our plan ensures we can deliver on the things that our customers care about and for the environment. This morning, we have received Ofwat’s feedback on those plans and are pleased that they assessed our document as meeting their requirements.  We have yet to review the detail of what is proposed by Ofwat – and it would be premature to comment further at this time.  We

Olvi plc: Transfer of Treasury Shares Under Performance Share Plans

Olvi plc           Stock Exchange Release 11 July 2024 at 10.00 am Olvi plc: Transfer of Treasury Shares Under Performance Share Plans The Board of Directors of Olvi plc has resolved on directed issuance of shares without consideration to transfer a total of 528 Olvi plc Series A shares held as treasury shares to the company's key employee under Performance Share Plans 2022–2024 and 2023–2025 in accordance with the terms of the plans upon the retirement of a key person. Information on the Performance Share Plans was provided in stock exchange releases on 27 May 2022 and 2 March

Volvo Trucks at IAA 2024: New trucks and technologies supporting the journey towards zero emissions and zero accidents

Volvo Trucks’ line-up at the IAA 2024 exhibition will be packed with proof points of Volvo’s determination to decarbonize transport and prevent accidents. Volvo will show trucks with battery-electric powertrains, fuel cells and renewable fuels in combustion engines – a strategy that enables sustainable transport today and tomorrow.IAA 2024 will be a great opportunity to experience all of Volvo Trucks’ latest trucks and technologies – supporting our journey towards zero emissions and zero accidents Volvo Trucks at IAA 2024 will be a demonstration of a global product range that has never

Misen Energy AB (publ) will be delisted and last day of trading is 24 July 2024

Misen Energy AB (publ) ("Misen" or the "Company") announced on 10 July 2024 that the Company has applied for delisting of the Company's shares from Nasdaq First North Growth Market in Stockholm. Nasdaq Stockholm has approved the Company's application for delisting.The Board of Directors of Misen resolved on 10 July 2024 to apply for delisting of the Company's shares from Nasdaq First North Growth Market in Stockholm. According to the decision of Nasdaq Stockholm, Misen's shares will be delisted from Nasdaq First North Growth Market. The last day of trading in the Company's shares will be 24

Invitation for presentation of Pricer’s interim report for the second quarter 2024

Pricer AB will present its interim report for the second quarter 2024 in a webcast on July 18 at 13.00 CET.According to the financial calendar, Pricer will publish the report for the second quarter 2024 on Thursday, July 18 at approximately 7.30 am CET. Pricer hereby invites to a presentation of the report on the same day. Magnus Larsson, President and CEO, and Claes Wenthzel, acting CFO, will present the report and answer questions. Date: July 18, 2024 Time: 13.00 CET Link to the webcast: https://financialhearings.com/event/48514 

Cell Impact has been awarded silver medal by EcoVadis

EcoVadis is the world’s most trusted provider of business sustainability ratings and has recently awarded Cell Impact AB a silver medal.EcoVadis’ thorough evaluation of Cell Impact’s operational sustainability practices has resulted in a rating of 72/100 and thus placed Cell Impact in the top 94 percent among all companies rated in the past year – 46 percent above the industry average. “The EcoVadis rating validates and demonstrates our commitment to sustainability and supports our company mission to help transform the global energy system and reduce the world's dependency on fossil

Presentation of Probi’s Q2 Report 2024

Probi’s report for the second quarter 2024 will be published on Tuesday, 16 July at 8.00 a.m. CET. In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CEO Anita Johansen and CFO Per Lindblad will present and comment on the report. The presentation and presentation material can be obtained via www.probi.com or https://ir.financialhearings.com/probi-q2-report-2024 

BioStock: PHI aims for US listing

Swedish Medtech Phase Holographic Imaging is making significant strides in the United States, establishing itself at the forefront of the rapidly growing regenerative medicine field. PHI is now taking an important step by applying for listing its shares in the US OTCQB market to enhance its presence and opportunities in the US. BioStock talked to CEO Patrik Eschricht to learn more about what this means for the company.Read the full article at biostock.se : https://www.biostock.se/2024/07/phi-aims-for-us-listing/ This is a press release from BioStock -

Distinct T-cell signatures observed at different stages of type 1 diabetes development

A study conducted at the University of Eastern Finland found distinct signatures in CD8-positive T cells in blood samples from children with newly diagnosed type 1 diabetes and in autoantibody-positive children who later developed type 1 diabetes. The study was published in the journal Diabetes. Type 1 diabetes is an autoimmune disease which usually develops in childhood. The symptomatic onset of type 1 diabetes results from a T-cell mediated destruction of insulin-producing beta cells in the pancreas. CD4-positive helper T cells orchestrate the autoimmune response, while CD8-positive

Aquaporin secures order with large EMEA water treatment company

Aquaporin is pleased to announce that it has secured an order valued at USD 300,000 from a large water treatment company in the EMEA region. This latest order comes from a recurring customer specializing in treating industrial wastewater, underscoring the strong, ongoing partnership between the two companies.The customer serves various market segments, including industries such as semiconductors, industrial plants, pharmaceuticals, and sewage treatment. The order consists of a variety of membrane modules from the CLEAR series, but predominantly CLEAR Classic 8040 and CLEAR Classic 4040. "

Re: Dividend Payment

For Immediate Release:       11 July 2024 ARK INVEST UCITS ICAV Re: Dividend Payment   The Directors of ARK INVEST UCITS ICAV (the “Fund”) wish to announce the following dividend paid by the Fund for the semi-annual dividend. Announcement Date: 11 July 2024 Ex-Date:  18 July 2024 Record Date:  19 July 2024 Payment Date:  30 July 2024   +------------------------+------------+--------+----------------+|Sub-Fund/Share Class |ISIN |Currency|Amount per Share|+------------------------+------------+--------+----------------+|RIZE GLOBAL SUSTAINABLE

Interim report January – June 2024: Continued strong profit and high rate of acquisitions

During the period, operational and financial progress remained strong due to rent increases, new development projects, new and extended rental contracts and positive acquisition effects.· Rental income increased by 19%, amounting to SEK 335 m (280). · Net operating income increased by 23%, amounting to SEK 286 m (232). · Profit from property management increased by 26% and amounted to SEK 182 m (145). · Earnings per share amounted to SEK 1.45 (0.65). · Net asset value (NAV) per share increased by 7% in the period and amounted to SEK 26.97. · Value changes in investment

John Mattson enters unique partnership with Stockholm Exergi to help with the transition of Stockholm’s energy system

Property company John Mattson and the energy company Stockholm Exergi have entered an agreement aimed at securing the long-term supply of district heating to John Mattson’s property portfolio and with the shared objective of reaching net zero for district heating production for the Stockholm region. The partnership entails investment by John Mattson in Stockholm Exergi’s transition of district heating over a longer period. At the same time, John Mattson is securing the supply of cost-effective and sustainable district heating for its properties.John Mattson’s investment will support

Notification of major holding in Kindred Group plc

Kindred Group plc (Kindred) hereby announces that it, on 10 July 2024, has received a notification of major holding from JPMorgan Chase & Co, a company with its registered office in Wilmington, Delaware, USA. The notification refers to a decrease in the number of shares and voting rights in Kindred held by JPMorgan Chase & Co.According to the notification, JPMorgan Chase & Co held 4.89% of the shares and voting rights in Kindred as of 05 July 2024. The relevant chain of controlled undertakings can be found in the notification, of which a copy can be found on Kindred’s website: https://

Faron Announces Positive FDA Feedback

Faron Pharmaceuticals Ltd.   (“Faron” or the “Company”)     Inside Information: Faron Announces Positive FDA Feedback   Company announcement, Inside Information, 11 July 2024 at 7:00 a.m. BST / 9:00 a.m. EEST   Key highlights -          Faron had a formal meeting with the FDA to discuss the registrational clinical development plan for bexmarilimab in the treatment myelodysplastic syndrome (MDS). -          The FDA acknowledged the difficulties of running a randomized study with a comparator in the relapsed / refractory setting (r/r) and instead proposed that

Implantica announces new health-economics data publication showing RefluxStop™’s superior cost-effectiveness for the Swiss healthcare system

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, reports the study, “Analysis of Cost-Effectiveness in Switzerland for a New Implantable Device to Treat Chronic Gastroesophageal Reflux Disease,” was published recently by the Journal of Medical Economics %20is,MSA%5D)%20in%20selected%20cases)1.The comprehensive health economic analysis published in this study found that RefluxStop™ is highly likely to be a cost-effective treatment for GERD

ForCrowd European Licence

11 July 2024 Quantum Blockchain Technologies Plc (”QBT” or “the Company”)     Forcrowd Update   The Board of Quantum Blockchain Technologies (AIM: QBT) is pleased to provide an update on its investee company, Forcrowd Srl ("Forcrowd"), the Italian equity-crowdfunding platform, in which it holds a 41% stake.   Forcrowd has recently secured registration with the European Securities and Markets Authority (“ESMA”) as an authorised provider of crowdfunding services per Regulation (EU) 2020/1503 with resolution 23169. This registration was achieved through a rigorous

High customer activity and strong results

DNB’s profit in the second quarter of 2024 was NOK 10.8 billion. This is NOK 1.3 billion, or 13.8 per cent, higher than the corresponding quarter of last year. The results were strong in all customer segments, and were supported by a stable Norwegian economy, with low unemployment and a higher activity level than expected.  Residential property prices have increased by 8 per cent so far this year. At the same time, the market for sale of new builds appears to have bottomed out, and several players in the sector will be working on new housing projects in the time ahead. “Increasing

Sweco wins SEK 400 million contract from the Swedish Transport Administration for project planning of a new railway along parts of the East Coast Line between Uppsala and Stockholm

Sweco will assist the Swedish Transport Administration with various consulting services to enable an extensive expansion of stretches of the East Coast Line between Uppsala and Stockholm. The order value for Sweco is estimated at about SEK 400 million. The contract, which will run from 2024 until 2035, will comprise project planning in railways, roads and road structures, building construction, architecture, water and sewage as well as consulting in environmental and digital solutions. The aim of the expansion “Four tracks Uppsala 

Read original

A year of innovation to continue Ovako’ s sustainability journey

Ovako has published its Sustainability Report  for the Financial Year 2023, demonstrating its continued leadership in sustainability, and inviting partners to join in collaborative efforts towards a sustainable society.On average Ovako’s steel products consist of 97 percent recycled steel. Since 2015, Ovako has reduced its carbon emissions per tonne steel from operations with 56 percent and the “cradle-to-gate” carbon footprint from Ovako’s steel products is 80 percent lower than the global average. The Sustainability

Read original

Hydrogen flight looks ready for take-off with new advances

The possibility of hydrogen-powered flight means greater opportunities for fossil-free travel, and the technological advances to make this happen are moving fast. New studies from Chalmers University of Technology, in Sweden, show that almost all air travel within a 750-mile radius (1200 km) could be made with hydrogen-powered aircraft by 2045, and with a novel heat exchanger currently in development, this range could be even further.   “If everything falls into place, the commercialisation of hydrogen flight can go really fast now. As early as 2028, the first commercial

Vår Energi: Second quarter and first half 2024 trading update

Sandnes, Norway, 11 July 2024: Vår Energi ASA (OSE: VAR, the "Company") will publish its financial report for the second quarter and first half 2024 on Tuesday 23 July. Today, the Company provides an update on production, sales volumes and other relevant items. The average production of 293 kboepd in the first half of 2024 is in the upper end of the guided range for the period and the Company is on track to meet the full year production guidance of 280 to 300 kboepd. Net production of oil, liquids and natural gas averaged 287 kboepd for the second quarter of 2024, a decrease of 4%

There are no items matching the current filter
There are no more items matching the current filter
Back to top